Achieve Life Sciences, Inc. (ACHV)
NASDAQ: ACHV · Real-Time Price · USD
4.290
-0.070 (-1.61%)
Feb 11, 2026, 2:08 PM EST - Market open
Achieve Life Sciences Employees
Achieve Life Sciences had 25 employees as of December 31, 2024. The number of employees increased by 3 or 13.64% compared to the previous year.
Employees
25
Change (1Y)
3
Growth (1Y)
13.64%
Revenue / Employee
n/a
Profits / Employee
-$2,093,840
Market Cap
228.37M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 25 | 3 | 13.64% |
| Dec 31, 2023 | 22 | 2 | 10.00% |
| Dec 31, 2022 | 20 | 4 | 25.00% |
| Dec 31, 2021 | 16 | 3 | 23.08% |
| Dec 31, 2020 | 13 | -1 | -7.14% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Humacyte | 220 |
| Protalix BioTherapeutics | 213 |
| Alector | 156 |
| Cabaletta Bio | 151 |
| Heron Therapeutics | 122 |
| MediWound | 111 |
| Orchestra BioMed Holdings | 70 |
| Camp4 Therapeutics | 55 |
ACHV News
- 6 days ago - Achieve Life Sciences: A Binary Bet With Cytisinicline And A Potential 2026 Launch - Seeking Alpha
- 7 days ago - Achieve Life Sciences: Could Be The Best 'Tobacco' Stock For 2026 - Strong Buy - Seeking Alpha
- 11 days ago - Achieve Life Sciences Announced Granting of New Hire Inducement Awards - GlobeNewsWire
- 4 weeks ago - Achieve Life Sciences Confirms Promotion of Dr. Mark Rubinstein to Chief Medical Officer - GlobeNewsWire
- 7 weeks ago - Achieve Life Sciences to Host Meetings During the J.P. Morgan Healthcare Conference Week - PRNewsWire
- 3 months ago - Achieve Life Sciences, Inc. (ACHV) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Achieve Life Sciences Reports Third Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program - GlobeNewsWire
- 3 months ago - Achieve Life Sciences Meets Key Milestones Advancing Cytisinicline NDA for Smoking Cessation - GlobeNewsWire